A-A-54606
COMMERCIAL ITEM DESCRIPTION
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification () which is cancelled.
Salient characteristics:
Shall be Theophylline and Guaifenesin Capsules.
All ingredients shall be of a pharmaceutical grade.
Each soft gelatin capsule shall contain 150 mg of anhydrous Theophylline and 90 mg of Guaifenesin within the applicable assay limits.
Each capsule shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The capsules shall be free from defects which detract from their appearance or impair their serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business